QS Investors, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 307 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$316,000
+4.3%
3,1750.0%0.00%0.0%
Q3 2020$303,000
-79.7%
3,175
-76.2%
0.00%
-81.0%
Q2 2020$1,495,000
+53.8%
13,3650.0%0.02%
+40.0%
Q1 2020$972,000
-30.2%
13,365
+0.6%
0.02%
+7.1%
Q4 2019$1,392,000
+4.4%
13,290
-0.7%
0.01%
-6.7%
Q3 2019$1,333,000
-12.8%
13,3900.0%0.02%
-6.2%
Q2 2019$1,529,000
-11.3%
13,390
-2.3%
0.02%
-15.8%
Q1 2019$1,724,000
+2398.6%
13,710
+2625.6%
0.02%
+1800.0%
Q4 2018$69,000
-50.0%
5030.0%0.00%0.0%
Q3 2018$138,000
+32.7%
5030.0%0.00%0.0%
Q2 2018$104,000
+25.3%
5030.0%0.00%0.0%
Q1 2018$83,000
+20.3%
5030.0%0.00%0.0%
Q4 2017$69,000
+1.5%
5030.0%0.00%0.0%
Q3 2017$68,000
+11.5%
5030.0%0.00%0.0%
Q2 2017$61,000
+15.1%
5030.0%0.00%
Q1 2017$53,000
+5200.0%
503
+16666.7%
0.00%
Q4 2016$1,0000.0%30.0%0.00%
Q3 2016$1,0000.0%3
+50.0%
0.00%
Q2 2016$1,0000.0%2
-60.0%
0.00%
Q1 2016$1,0000.0%5
+150.0%
0.00%
Q4 2015$1,00020.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$25,673,00016.20%
Stonepine Capital Management, LLC 160,919$11,702,00012.38%
VILLERE ST DENIS J & CO LLC 635,758$46,232,0003.94%
CARDINAL CAPITAL MANAGEMENT LLC /CT 982,049$71,415,0003.51%
Elk Creek Partners, LLC 246,251$17,907,0003.08%
Tygh Capital Management, Inc. 151,792$11,038,0002.47%
Roubaix Capital, LLC 20,034$1,457,0002.21%
Conestoga Capital Advisors, LLC 648,603$47,166,0001.38%
RICE HALL JAMES & ASSOCIATES, LLC 338,376$24,607,0001.38%
Ikarian Capital, LLC 200,000$14,544,0001.09%
View complete list of LIGAND PHARMACEUTICALS INC shareholders